Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sandra A Springer

Showing results (41-50 of 121) with videos related to

Pageof 13
Sort By:
Journal of Addiction Medicine|February 4, 2020
A Call to Action to Combat the Opioid Epidemic Among WomenSandra A Springer, Breanne E Biondi, Cynthia Frank, et al.
Expert Review of Clinical Pharmacology|July 1, 2024
Considerations when prescribing opioid agonist therapies for people living with HIVAdati Tarfa, Audun J Lier, Sheela V Shenoi, et al.
Contemporary Clinical Trials|January 4, 2014
Design and methods of a double blind randomized placebo-controlled trial of extended-release naltrexone for alcohol dependent and hazardous drinking prisoners with HIV who are transitioning to the communitySandra A Springer, Frederick L Altice, Maua Herme, et al.
Open Forum Infectious Diseases|December 5, 2022
Evaluation of the Impact of HIV Serostatus on the Hepatitis C Virus Care Cascade and Injection Drug Use Among Persons Initiating Medication Treatment for Opioid Use DisorderAudun J Lier, Brent Vander Wyk, Angela Di Paola, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 17, 2011
Public health implications for adequate transitional care for HIV-infected prisoners: five essential componentsSandra A Springer, Anne C Spaulding, Jaimie P Meyer, et al.
Plos One|June 22, 2012
Retention on buprenorphine is associated with high levels of maximal viral suppression among HIV-infected opioid dependent released prisonersSandra A Springer, Jingjun Qiu, Ali Shabahang Saber-Tehrani, et al.
Infectious Disease Clinics of North America|August 13, 2020
The Impact of Medications for Opioid Use Disorder on Hepatitis C Incidence Among Incarcerated Persons: A Systematic ReviewNikhil Seval, Alysse Wurcel, Craig G Gunderson, et al.
Drug and Alcohol Dependence|August 14, 2010
A systematic review of the impact of alcohol use disorders on HIV treatment outcomes, adherence to antiretroviral therapy and health care utilizationMarwan M Azar, Sandra A Springer, Jaimie P Meyer, et al.
Drug and Alcohol Dependence|November 13, 2015
Correlates of retention on extended-release naltrexone among persons living with HIV infection transitioning to the community from the criminal justice systemSandra A Springer, Shan-Estelle Brown, Angela Di Paola, et al.
HIV Clinical Trials|August 28, 2007
Antiretroviral treatment regimen outcomes among HIV-infected prisonersSandra A Springer, Gerald H Friedland, Gheorghe Doros, et al.
Pageof 13

Showing results (41-50 of 121) with videos related to

Sort By:
Pageof 13
Journal of Addiction Medicine|February 4, 2020
A Call to Action to Combat the Opioid Epidemic Among WomenSandra A Springer, Breanne E Biondi, Cynthia Frank, et al.
Expert Review of Clinical Pharmacology|July 1, 2024
Considerations when prescribing opioid agonist therapies for people living with HIVAdati Tarfa, Audun J Lier, Sheela V Shenoi, et al.
Contemporary Clinical Trials|January 4, 2014
Design and methods of a double blind randomized placebo-controlled trial of extended-release naltrexone for alcohol dependent and hazardous drinking prisoners with HIV who are transitioning to the communitySandra A Springer, Frederick L Altice, Maua Herme, et al.
Open Forum Infectious Diseases|December 5, 2022
Evaluation of the Impact of HIV Serostatus on the Hepatitis C Virus Care Cascade and Injection Drug Use Among Persons Initiating Medication Treatment for Opioid Use DisorderAudun J Lier, Brent Vander Wyk, Angela Di Paola, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 17, 2011
Public health implications for adequate transitional care for HIV-infected prisoners: five essential componentsSandra A Springer, Anne C Spaulding, Jaimie P Meyer, et al.
Plos One|June 22, 2012
Retention on buprenorphine is associated with high levels of maximal viral suppression among HIV-infected opioid dependent released prisonersSandra A Springer, Jingjun Qiu, Ali Shabahang Saber-Tehrani, et al.
Infectious Disease Clinics of North America|August 13, 2020
The Impact of Medications for Opioid Use Disorder on Hepatitis C Incidence Among Incarcerated Persons: A Systematic ReviewNikhil Seval, Alysse Wurcel, Craig G Gunderson, et al.
Drug and Alcohol Dependence|August 14, 2010
A systematic review of the impact of alcohol use disorders on HIV treatment outcomes, adherence to antiretroviral therapy and health care utilizationMarwan M Azar, Sandra A Springer, Jaimie P Meyer, et al.
Drug and Alcohol Dependence|November 13, 2015
Correlates of retention on extended-release naltrexone among persons living with HIV infection transitioning to the community from the criminal justice systemSandra A Springer, Shan-Estelle Brown, Angela Di Paola, et al.
HIV Clinical Trials|August 28, 2007
Antiretroviral treatment regimen outcomes among HIV-infected prisonersSandra A Springer, Gerald H Friedland, Gheorghe Doros, et al.
Pageof 13